BACKGROUND AND PURPOSEThe endocannabinoid and corticotropin-releasing factor (CRF) systems have been implicated in several long-lasting behavioural effects of prior cocaine experience. The present experiments were designed to probe functional interactions between endocannabinoids and CRF by testing the role of cannabinoid CB1 receptors in cocaine-related behaviours induced or mediated by CRF.
EXPERIMENTAL APPROACHIn Experiment 1, rats trained to self-administer cocaine were pretreated with the CB1 receptor antagonist, AM251 (0, 10, 100 or 200 mg, i.c.v.), before tests for reinstatement in response to CRF (0, 0.5 mg, i.c.v.), intermittent footshock stress (0, 0.9 mA) or cocaine (0, 10 mg·kg -1 , i.p.). In Experiment 2, rats pre-exposed to cocaine (15-30 mg·kg
KEY RESULTSPretreatment with AM251 selectively interfered with CRF-, but not footshock-or cocaine-induced reinstatement. AM251 blocked the expression of behavioural sensitization induced by challenge injections of both CRF and cocaine.
CONCLUSIONS AND IMPLICATIONSThese findings reveal a mediating role for CB1 receptor transmission in the effects of CRF on cocaine-related behaviours.
Abbreviations2-AG, 2-arachidonoylglycerol; BLA, basolateral amygdala; BNST, bed nucleus of the stria terminalis; CeA, central nucleus of the amygdala; CPP, conditioned place preference;